Tolerance to nitrates with enhanced radical formation suppressed by carvedilol

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 6, 1999, Pages 800-805

  Fink, B ^a   Schwemmer, M ^a   Fink, N ^a   Bassenge, E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Adrenergic antagonists; Free radicals; Heart failure; Nitric oxide; Nitrovasodilators

Indexed keywords

ASCORBIC ACID; BM 910228; CALCIUM; CARVEDILOL; CYCLIC GMP; DRUG METABOLITE; GLYCERYL TRINITRATE; NITRIC ACID DERIVATIVE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTERY DIAMETER; ARTICLE; CORONARY HEMODYNAMICS; DRUG EFFICACY; DRUG TOLERANCE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOCYTE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD PLATELETS; CALCIUM; CARBAZOLES; CYCLIC GMP; DOGS; FEMALE; MALE; NITROGLYCERIN; NITROPRUSSIDE; PLATELET AGGREGATION; PROPANOLAMINES; REACTIVE OXYGEN SPECIES; VASODILATOR AGENTS;

EID: 0032735467     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199912000-00005     Document Type: Article

References (35)

1. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996;334: 1349-55.
2. Weglicki WB, Mak IT, Simic MG. Mechanisms of cardiovascular drugs as antioxidants. J Mol Cell Cardiol 1990;22:1199-208.
3. Yue TL, Cheng HY, Lysko PG, et al. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharmacol Exp Ther 1992;263:92-8.
4. Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RRJ. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity. J Hypertens 1993;11: S41-8.
5. Katz SD, Rao R, Berman JW, et al. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure: relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation 1994;90:12-6.
6. Münzel T, Kurz S, Rajagopalan S, et al. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug. J Clin Invest 1996;98:1465-70.
7. Rajagopalan S, Kurz S, Münzel T, et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-23.
8. Jafri SM, Ozawa T, Mammen E, Levine TB, Johnson C, Goldstein S. Platelet function, thrombin and fibrinolytic activity in patients with heart failure. Eur Heart J 1993;14:205-12.
9. Bassenge E, Fink N, Fink B. Effects of oxidant stress circumvented by antioxidants vitamin C or by β-blocker carvedilol metabolite BM 910228. Pfluegers Arch Eur J Physiol 1998;435:R74.
10. Bassenge E, Skatchkov M, Fink B, Miyauchi T, Sugishita Y. Regulation of vascular tone by endogenous and exogenous NO-donors. The Heart (Japan) 1996;6:539-46.
11. Kramer JH, Weglicki WB. A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts. Free Radic Biol Med 1996;21:813-25.
12. Fink B, Bassenge E. Unexpected, tolerance-devoid vasomotor and platelet actions of pentaerytrityl tetranitrate. J Cardiovasc Pharmacol 1997;30:831-6.
13. Dikalov S, Skatchkov M, Fink B, Sommer O, Bassenge E. Formation of reactive oxygen species in various vascular cells during glyceryltrinitrate metabolism. J Cardiovasc Pharmacol Ther 1998; 3:51-62.
14. Münzel T, Harrison DG. Evidence for a role of oxygen-derived free radicals and protein kinase C in nitrate tolerance. J Mol Med 1997;75:891-900.
15. Dikalov S, Fink B, Skatchkov M, Bassenge E. Formation of reactive oxygen species by PETN and GTN in vitro and development of nitrate tolerance. J Pharmacol Exp Ther 1998;286:938-44.
16. Münzel T, Bassenge E. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo. Circulation 1996;93:2052-8.
17. Bassenge E, Fink N, Skatchkov M, Fink B. Dietary supplement with vitamin C prevents nitrate tolerance. J Clin Invest 1998;102: 67-71.
18. Dikalov S, Fink B, Skatchkov M, Bassenge E. Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: effect of vitamin C. Free Radic Biol Med 1999;27:169-75.
19. 2-receptor externalization. Pflugers Arch Eur J Physiol 1998; 435:R198.
20. Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y. The preventive effect of vitamin E on nitrate tolerance. Circulation 1996;94S:I-503-41.
21. Münzel T, Holtz J, Mülsch A, Stewart DJ, Bassenge E. Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist. Circulation 1989;79:188-97.
22. Bassenge E, Fink B. Tolerance to nitrates and simultaneous upregulation of platelet activity prevented by enhancing antioxidant state. Naunyn Schmiedebergs Arch Pharmacol 1996;353:363-7.
23. Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y. Preventive effects of carvedilol on nitrate tolerance: a randomized, double-blind, placebo-controlled comparative study between carvedilol and arotinolol. J Am Coll Cardiol 1998;32:1201-6.
24. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
25. 2+ and on aggregation of human platelets. Eur J Pharmacol Mol Pharmacol 1993;244:37-47.
26. Dikalov S, Skatchkov M, Bassenge E. Spin trapping of superoxide radicals and peroxynitrite by 1-hydroxy-3-carboxypyrrolidine and 1-hydroxy-2,2,6,6-tetramethyl-4-oxo-piperidine and the stability of corresponding nitroxyl radicals towards biological reductants. Biochem Biophys Res Commun 1997;231:701-4.
27. Münzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. J Clin Invest 1995;95:187-94.
28. Skatchkov M, Larina L, Larin A, Fink N, Bassenge E. Urinary nitrotyrosine content as a marker of peroxynitrite-induced tolerance to organic nitrates. J Cardiovasc Pharmacol Ther 1997;2:85-96.
29. Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y. Randomized, double-blind, placebo-controlled study of ascorbate on the preventive effect of nitrate tolerance in patients with congestive heart failure. Circulation 1998;97:886-91.
30. Fink B, Sommer O, Bassenge E. Upregulation of NADH-oxidase activity in platelets during induction of nitrate tolerance. FASEB J 1998;12:718.
31. Dikalov S, Skatchkov M, Fink B, Sommer O, Stalleicken D, Bassenge E. Most nitrovasodilators except PETN induce formation of reactive oxygen species and tolerance. Eur Heart J 1997;18 (suppl):294-4.
32. Schwemmer M, Bassenge E. Assembly and characterization of canine heart endothelial nitric oxide synthase cDNA and 5′-flanking sequence by homology (RT-)PCR cloning: Nitric Oxide 1999;3:254-64.
33. Münzel T, Giaid A, Kurz S, Stewart DJ, Harrison DG. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci U S A 1995;92:5244-8.
34. Kurz S, Hink U, Nickenig G, Borthayre AB, Harrison DG, Münzel T. Evidence for a causal role of the renin angiotensin system in nitrate tolerance. Circulation 1999;24:3181-7.
35. Belch JJF, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J 1991;65:245-8.